Efforts toward SDGs

In its implementation of CSR-based Management, Sumitomo Pharma has identified material issues (Materiality) to prioritize in reference to the United Nations' Sustainable Development Goals (SDGs) that were adopted at the UN Sustainable Development Summit in September 2015. The Company believes that addressing these material issues through its business activities is an effective way to contribute to the achievement of SDGs. The Company strives to solve social issues by boosting its efforts in the development of innovative pharmaceutical products and healthcare solutions in focus areas with high unmet medical needs (psychiatry & neurology, oncology and regenerative medicine/cell therapy), as well as in other diverse fields.

Basic Policy

The United Nations SDGs are composed of 17 goals and 169 targets to be accomplished by 2030. While concentrating its efforts primarily on Goal 3: Good health and well-being, Sumitomo Pharma is also working actively to address other areas of focus, such as Goal 17: Partnerships for the goals; Goal 12: Responsible consumption and production; and Goal 8: Decent work and economic growth, through a range of initiatives.

Sumitomo Pharma's Top Priority Sustainable Development Goals and Targets

Goals Targets
3 Good Health and Well-being 3.4
By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
3.3
By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases.
8 Decent Work and Economic Growth 8.5
By 2030, achieve full and productive employment and decent work for all women and men, including for young people and persons with disabilities, and equal pay for work of equal value.
12 Responsible Consumption and Production 12.4
By 2020, achieve the environmentally sound management of chemicals and all wastes throughout their life cycle, in accordance with agreed international frameworks, and significantly reduce their release to air, water and soil in order to minimize their adverse impacts on human health and the environment.
17 Partnerships For the Goals 17.17
Encourage and promote effective public, public-private and civil society partnerships, building on the experience and resourcing strategies of partnerships.

Sumitomo Pharma's Initiatives Related to SDGs

1 No Poverty ・Support for households in need (aid to disaster-affected areas, support for Kodomo Shokudo project to feed impoverished children across the country) (1.5)
2 Zero Hunger ・Support for developing countries through company cafeterias and matching donations (2.1)
・Initiatives for safe delivery and sound child growth in Cambodia (2.2)
・Support for children of households in need (aid to disaster-affected areas, support for Kodomo Shokudo project to feed impoverished children across the country) (2.1)
3 Good Health and Well-Being ・Pharmaceutical business (psychiatry & neurology, oncology, regenerative medicine/cell therapy, infectious diseases, etc.) and exploring the Frontier business (3.4)
・Addressing product safety and adverse reactions (3.4)
・Providing and collecting product information (healthcare professionals) (3.4)
・Initiatives to improve medicine-related literacy (3.4)
・Operation of health and medical information website (3.4)
・Initiatives aimed at appropriate use of antibiotics and countermeasures to antimicrobial resistance (AMR) (3.3)
・Participation in GHIT Fund to develop medicines for malaria and other infectious diseases (3.3)
・Participation in Access Accelerated to improve access to medicines for non-communicable diseases (NCDs) in developing countries(3.4)
・Initiatives for safe delivery and sound child growth in Cambodia (3.1)
・Support for children with intractable diseases (3.2)
・Supporting daycare for sick children of single-parent families and families raising children with disabilities (3.8)
・Health and productivity management (welfare of employees and promoting mental health) (3.8)
4 Quality education ・Initiatives for safe delivery and sound child growth in Cambodia (4.2, 4.5)
・Operation of website for children (4.4)
・Supporting initiatives of younger generations to solve social issues in their communities, etc. (4.4, 4.7)
・Sumitomo Scholarship Project (China) (4.3)
5 Gender Equality ・Supporting women's active participation (5.5)
・Encouraging men to participate in child care (5.4)
・Participation in IkuBoss Alliance (5.4)
・Initiatives to promote understanding of LGBTQ (5.5)
6 Clean water and sanitation ・Support of sanitation infrastructure in Burkina Faso (6.2)
・Water use reduction by effectively using water resources (6.4)
・Wastewater management at research centers, plants and facilities (6.3)
7 Affordable and clean energy ・Effective use of energy via COOL CHOICE, etc. (7.3)
・Utilization of solar power generating systems (7.2)
・Utilizing fuel-efficient business vehicles (7.3)
8 Decent work and economic growth ・Promotion of Work Style Innovation aimed at more sophisticated work styles and a virtuous cycle in work-life balance (8.5)
・CSR procurement (8.7)
・Supporting active participation by people with disabilities through appropriate placement (8.5)
・Health and productivity management (welfare of employees and promoting mental health) (8.5)
9 Industry, innovation and infrastructure ・Sustainable manufacturing, logistics and procurement through development of an environmental conservation system, etc. (9.4)
・Utilizing external resources (9.5)
・Collaboration with external institutions through PRISM open innovation program (9.5)
・Support for research activities through the Japan Epilepsy Research Foundation (9.5)
・Participation in GHIT Fund to develop medicine for malaria and other infectious diseases (9.5)
10 Reduced Inequalities ・Supporting active participation by people with disabilities through appropriate placement (10.2)
・Supporting independence and social reintegration of people with disabilities (10.2)
・CSR procurement (10.2, 10.3)
・Support for development of healthcare infrastructure and capacity building in developing countries (10.2)
・Participation in Access Accelerated to improve access to medicines for NCDs in developing countries (10.2)
・Initiatives for safe delivery and sound child growth in Cambodia (10.2)
・Support for developing countries through company cafeterias and matching donations (10.2)
11 Sustainable cities and communities ・Product development considering the impact of climate change and water risks (11.6)
・Maintenance and improvement of waste recycling rate (11.6)
・Risk mitigation of environmental accidents (11.6)
・Initiatives to reduce environmental impact throughout products' lifecycles (11.6)
12 Responsible consumption and production ・Maintenance and improvement of recycling rate for waste (12.4, 12.5)
・Risk mitigation of environmental accidents (12.4)
・Initiatives to reduce environmental impact throughout products' lifecycles (12.4, 12.5)
・Stable product supply and quality assurance (12.6)
・Risk mitigation of natural disasters (12.6)
13 Climate Action ・Responding to TCFD (13.1)
・Soliciting capital expenditure ideas to reduce CO2 emissions from within the company (13.1)
・Utilizing fuel-efficient business vehicles (13.1)
・Collaboration with Sumitomo Chemical group companies and Sumitomo Pharma's subsidiaries (SBT), and collaboration with supply chains (Scope3) (13.1)
・Effective use of energy via COOL CHOICE, etc. (13.1)
・Utilization of solar power generating systems (13.1)
・Initiatives to reduce environmental impact throughout products' lifecycles (13.1)
14 Life below water ・Risk mitigation of environmental accidents (14.1)
・Wastewater management at research centers, plants and facilities (14.1)
・Initiatives aimed at eco-friendly alternatives to plastic bottled beverages (14.1)
15 Life on land ・Initiatives for biodiversity in Sumitomo Pharma Forest in Kishiwada, Osaka, Japan (15.4)
・Supporting protection of the natural environment and biodiversity (15.4, 15.5)
・Preserving wildlife reserves (U.S.) (15.4)
16 Peace, justice and strong institutions ・Promoting corporate governance (16.5)
・Ensuring compliance (16.1, 16.5)
・CSR procurement (16.1, 16.2, 16.5)
17 Partnerships for the goals Partnership activities for sustainable development
・Industry-academia-government collaborative R&D (academic institutions, biotech companies, AMED, GHIT Fund, etc.)
・Access Accelerated
・IFPMA
・JPMA (Japan Pharmaceutical Manufacturers Association)
・People's Hope Japan
・CDP
・TABLE FOR TWO
・Future Code
・Malaria No More Japan
・Other